Mode
Text Size
Log in / Sign up

MIRA feasibility study in Dutch long-term care organizations shows good reliability and high acceptability among professionalsFeasibility study finds MIRA approach works for long-term care innovation

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider MIRA for assessing innovation readiness in long-term care, but note feasibility does not prove improved outcomes.

This mixed-method cross-sectional feasibility study evaluated the Maastricht Innovation Readiness Approach (MIRA) within 10 Dutch long-term care organizations for older adults. The intervention consisted of a questionnaire and a consensus meeting involving 173 participants who completed the MIRA Questionnaire at t1, 128 at t2, and 127 who attended the MIRA Consensus meeting. A one-month interval separated the two questionnaire completions. The study focused on feasibility rather than clinical efficacy.

The analysis found a mean perceived innovation readiness score of 6.6. Intrarater reliability of the MIRA Questionnaire was good, with an intraclass correlation coefficient > 0.75. Additionally, 88% of participants indicated gaining insight into their organization's innovation readiness, and 84% recommended the approach to other organizations. Participant evaluations highlighted the acceptability, suitability, and value of the method.

The authors note that it remains unclear whether conducting MIRA improves innovation readiness. Longitudinal studies are needed to follow organizations as they implement steps to improve innovation readiness and to explore how these contribute to successful innovation outcomes. The study did not report adverse events or discontinuations. Funding or conflicts of interest were not reported.

Practice relevance is limited to feasibility. MIRA is a feasible approach to assess innovation readiness in long-term care. It enhances internal awareness, supports group reflection across roles and disciplines, and may support structured progress in innovation readiness. Claims of improved innovation readiness or successful innovation outcomes must be interpreted cautiously given the study design and limitations.

A mixed-method cross-sectional feasibility study was conducted in Dutch long-term care organizations involving professionals in innovation. The research team used the Maastricht Innovation Readiness Approach, which includes a questionnaire and a consensus meeting, to evaluate how well the method works.

The study included 173 participants who completed the initial questionnaire, with 128 finishing a follow-up survey one month later. Results showed good intrarater reliability for the questionnaire and that 88% of participants felt the approach provided insight into their organization's readiness. Additionally, 84% recommended the method to other organizations.

However, the study has important limitations. It remains unclear whether conducting MIRA actually improves innovation readiness or leads to successful innovation outcomes. Longitudinal studies are needed to follow organizations over time as they implement steps to improve readiness. This guideline suggests the approach is feasible for assessing readiness and supporting group reflection, but it does not prove the method causes better innovation results.

What this means for you:
MIRA is a feasible way to assess innovation readiness, but its impact on outcomes needs more study.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Innovation in long-term care for older adults is essential to manage challenges such as a growing demand and workforce shortages. Organizations with higher innovation readiness are more likely to adopt and sustain innovations effectively. However, an approach indicating the innovation readiness of long-term care organizations for older adults is lacking. To address this, the Maastricht Innovation Readiness Approach (MIRA) was developed to (1) increase understanding about innovation readiness, (2) facilitate the organization's self-assessment of innovation readiness, and (3) inspire the organizational conversation on how to become better at innovating. The aim of this work was to examine the feasibility of MIRA and explore whether it could be successfully applied in long-term care practice. MIRA consists of a questionnaire and a consensus meeting. To evaluate the MIRA approach, a mixed-method cross-sectional feasibility study was conducted in 10 Dutch long-term care organizations. The study evaluated scores on the MIRA Questionnaire, assessed its intrarater reliability, and examined the feasibility of both the MIRA Questionnaire and the MIRA Consensus meeting. Professionals (involved in innovation) were asked to (1) complete the MIRA Questionnaire and additional closed-ended questions about its feasibility twice online (1-month interval), (2) participate in the Consensus meeting and verbally answer open questions, and (3) complete a questionnaire directly following the consensus meeting on its feasibility. In total, 173 participants completed the MIRA Questionnaire at t1 (#128 at t2); 127 participants attended the MIRA Consensus meeting (t1). The mean perceived innovation readiness score was 6.6 (scale 1–10). Intrarater reliability of the MIRA Questionnaire was good (intraclass correlation coefficient > 0.75). Participants evaluated MIRA as acceptable, suitable, and valuable: 88% indicated that MIRA provided insight into their organization's innovation readiness, and 84% would recommend it to other organizations. Interestingly, participants suggested annual use of MIRA. MIRA is a feasible approach to assess innovation readiness in long-term care. It enhances internal awareness, supports group reflection across roles and disciplines, and may support structured progress in innovation readiness. However, it remains unclear whether conducting MIRA improves innovation readiness. Longitudinal studies are needed to follow organizations as they implement steps to improve innovation readiness and to explore how these contribute to succesful innovation outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.